SI8810183A8 - Postopek za pridobivanje kristalne natrijeve soli 5-klor-3-(2-tenoil)-2-oksindol-1-karboksamida - Google Patents

Postopek za pridobivanje kristalne natrijeve soli 5-klor-3-(2-tenoil)-2-oksindol-1-karboksamida Download PDF

Info

Publication number
SI8810183A8
SI8810183A8 SI8810183A SI8810183A SI8810183A8 SI 8810183 A8 SI8810183 A8 SI 8810183A8 SI 8810183 A SI8810183 A SI 8810183A SI 8810183 A SI8810183 A SI 8810183A SI 8810183 A8 SI8810183 A8 SI 8810183A8
Authority
SI
Slovenia
Prior art keywords
carboxamide
oxindole
chloro
thenoyl
sodium salt
Prior art date
Application number
SI8810183A
Other languages
English (en)
Slovenian (sl)
Inventor
Douglas John Meldrum Allen
Brian Thomas O'neill
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SI8810183A8 publication Critical patent/SI8810183A8/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SI8810183A 1987-02-02 1988-02-01 Postopek za pridobivanje kristalne natrijeve soli 5-klor-3-(2-tenoil)-2-oksindol-1-karboksamida SI8810183A8 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1987/000201 WO1988005656A1 (en) 1987-02-02 1987-02-02 Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
YU18388A YU46766B (sh) 1987-02-02 1988-02-01 Postupak za dobijanje anhidrovane, kristalne natrijumove soli 5-hlor-3-(2-tenoil)-2-ok-sindol-1-karboksamida

Publications (1)

Publication Number Publication Date
SI8810183A8 true SI8810183A8 (sl) 1996-08-31

Family

ID=22202263

Family Applications (1)

Application Number Title Priority Date Filing Date
SI8810183A SI8810183A8 (sl) 1987-02-02 1988-02-01 Postopek za pridobivanje kristalne natrijeve soli 5-klor-3-(2-tenoil)-2-oksindol-1-karboksamida

Country Status (42)

Country Link
US (1) US5036099A (fi)
EP (1) EP0277738B1 (fi)
JP (1) JPS63201184A (fi)
KR (1) KR900001422B1 (fi)
CN (1) CN1022324C (fi)
AP (1) AP52A (fi)
AR (1) AR243182A1 (fi)
AT (1) ATE73800T1 (fi)
AU (1) AU587736B2 (fi)
BG (1) BG51042A3 (fi)
CA (1) CA1335590C (fi)
CS (2) CS265250B2 (fi)
CY (1) CY1775A (fi)
DD (1) DD267490A5 (fi)
DE (1) DE3869149D1 (fi)
DK (1) DK44888A (fi)
EC (1) ECSP941082A (fi)
ES (1) ES2032955T3 (fi)
FI (1) FI89598C (fi)
GR (1) GR3004200T3 (fi)
HK (1) HK132695A (fi)
IE (1) IE60000B1 (fi)
IL (1) IL85277A (fi)
IN (1) IN171799B (fi)
IS (1) IS1533B (fi)
LV (1) LV10252B (fi)
MA (1) MA21171A1 (fi)
MY (1) MY102737A (fi)
NO (1) NO170581C (fi)
NZ (1) NZ223373A (fi)
OA (1) OA08710A (fi)
PH (1) PH26545A (fi)
PL (1) PL149550B1 (fi)
PT (1) PT86675B (fi)
RO (1) RO105052B1 (fi)
RU (1) RU2011381C1 (fi)
SG (1) SG27994G (fi)
SI (1) SI8810183A8 (fi)
UA (1) UA25898A1 (fi)
WO (1) WO1988005656A1 (fi)
YU (1) YU46766B (fi)
ZA (1) ZA88679B (fi)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function
US4861794A (en) * 1988-04-13 1989-08-29 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
US5118703A (en) * 1988-10-18 1992-06-02 Pfizer Inc. Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
DE68923673T2 (de) * 1988-10-18 1996-01-18 Pfizer Prodrogen von antiinflammatorischen 3-Acyl-2-oxindol-1-carboxamiden.
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
US5006547A (en) * 1990-03-19 1991-04-09 Pfizer Inc. Tenidap as an inhibitor of the release of elastase by neutrophils
US5122534A (en) * 1991-02-08 1992-06-16 Pfizer Inc. Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
DE4111305C2 (de) * 1991-04-08 1994-12-01 Mack Chem Pharm Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
AU7503496A (en) * 1995-12-19 1997-07-14 Pfizer Inc. Stable, long acting salts of indole derivatives for the treatment of joint diseases
EP0826685A1 (en) * 1996-08-21 1998-03-04 Pfizer Inc. Stable, long acting salts of carboxamides for the treatment of joint disease
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
US7407195B2 (en) 2004-04-14 2008-08-05 William Berson Label for receiving indicia having variable spectral emissivity values
US7651031B2 (en) 2004-10-25 2010-01-26 William Berson Systems and methods for reading indicium
US7931413B2 (en) * 2005-01-14 2011-04-26 William Berson Printing system ribbon including print transferable circuitry and elements
US7619520B2 (en) * 2005-01-14 2009-11-17 William Berson Radio frequency identification labels and systems and methods for making the same
US7728726B2 (en) * 2005-01-14 2010-06-01 William Berson Radio frequency identification labels
US7621451B2 (en) * 2005-01-14 2009-11-24 William Berson Radio frequency identification labels and systems and methods for making the same
IL274383B2 (en) 2017-11-02 2024-03-01 Accurate Medical Therapeutics Ltd Catheter for embolization with integral filter

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767653A (en) * 1971-06-28 1973-10-23 Squibb & Sons Inc Thiazines
GB1532413A (en) * 1974-12-23 1978-11-15 Union International Co Ltd Chenodeoxycholic acid
DE2613346C3 (de) * 1976-03-29 1981-07-23 Diamalt AG, 8000 München Monoklin kristalline Chenodesoxycholsäure und Verfahren zu ihrer Herstellung
DE3568776D1 (en) * 1984-02-07 1989-04-20 Pfizer 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
EP0155828B1 (en) * 1984-03-19 1990-09-19 Pfizer Inc. Process for making 2-oxindole-1-carboxamides and intermediates therefor
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents

Also Published As

Publication number Publication date
ECSP941082A (es) 1994-12-15
IL85277A (en) 1994-02-27
OA08710A (fr) 1989-03-31
DE3869149D1 (de) 1992-04-23
SG27994G (en) 1994-10-14
PL270415A1 (en) 1988-12-08
YU18388A (en) 1989-10-31
GR3004200T3 (fi) 1993-03-31
AP8800081A0 (en) 1987-11-01
DK44888A (da) 1988-08-03
YU46766B (sh) 1994-05-10
NO884329L (no) 1988-09-29
KR900001422B1 (ko) 1990-03-09
US5036099A (en) 1991-07-30
CS64888A2 (en) 1988-08-16
DK44888D0 (da) 1988-01-29
MY102737A (en) 1992-09-30
ATE73800T1 (de) 1992-04-15
DD267490A5 (de) 1989-05-03
CS354191A3 (en) 1992-04-15
EP0277738B1 (en) 1992-03-18
CN88100555A (zh) 1988-08-17
NO170581C (no) 1992-11-04
IE60000B1 (en) 1994-05-18
WO1988005656A1 (en) 1988-08-11
IS3309A7 (is) 1988-08-03
FI893647A0 (fi) 1989-08-01
BG51042A3 (en) 1993-01-15
KR880009961A (ko) 1988-10-06
MA21171A1 (fr) 1988-10-01
NZ223373A (en) 1989-06-28
AP52A (en) 1989-09-16
IS1533B (is) 1994-01-28
JPS63201184A (ja) 1988-08-19
LV10252B (en) 1995-04-20
HK132695A (en) 1995-09-01
CN1022324C (zh) 1993-10-06
JPH0576945B2 (fi) 1993-10-25
IE880269L (en) 1988-08-02
NO170581B (no) 1992-07-27
PL149550B1 (en) 1990-02-28
RO105052B1 (en) 1994-12-01
IN171799B (fi) 1993-01-09
UA25898A1 (uk) 1999-02-26
AU1116088A (en) 1988-08-04
IL85277A0 (en) 1988-07-31
FI89598B (fi) 1993-07-15
CY1775A (en) 1996-04-05
FI89598C (fi) 1993-10-25
AU587736B2 (en) 1989-08-24
PT86675A (pt) 1988-03-01
NO884329D0 (no) 1988-09-29
ZA88679B (en) 1989-09-27
CS265250B2 (en) 1989-10-13
ES2032955T3 (es) 1996-07-16
RU2011381C1 (ru) 1994-04-30
PH26545A (en) 1992-08-19
EP0277738A1 (en) 1988-08-10
LV10252A (lv) 1994-10-20
PT86675B (pt) 1992-07-31
AR243182A1 (es) 1993-07-30
CA1335590C (en) 1995-05-16

Similar Documents

Publication Publication Date Title
SI8810183A8 (sl) Postopek za pridobivanje kristalne natrijeve soli 5-klor-3-(2-tenoil)-2-oksindol-1-karboksamida
BR0215777B1 (pt) Composition, method for preparing the same, pharmaceutical composition for preventing and treating cardioischemia, cerebrosis, cerebral arterial oclusion and for improving micro-circulation of the brain, and use of compound
JP4654187B2 (ja) テクトリゲニンのイソフラボン誘導体、その調製、および有効成分としてこれを含む抗ウィルス剤
JP7264999B2 (ja) ２－（１－アシルオキシ－ｎ－ペンチル）安息香酸と塩基性アミノ酸またはアミノグアニジンによって形成される塩と、その製造方法及び用途
WO2015014089A1 (zh) 替格瑞洛的一水合物及其制备方法与在制药中的应用
CN111565708B (zh) 一种稳定的含有非甾体抗炎药衍生物的药物组合物
CN107922448B (zh) 一种氘代噻吩并哌啶衍生物、制备方法及其应用
JP2017534635A (ja) レバプラザン塩酸塩の結晶多形及びその調製方法
JP4657393B2 (ja) ドキサゾシン・メシレートの新規な形態ｉｉｉ
WO2022062401A1 (zh) 一种泰格列净的制备方法
CN100422133C (zh) 2-（α-羟基戊基）苯甲酸盐及其制法和用途
CS195746B2 (en) Process for preparing crystalline methanolate of natrium salt of cephamandole
CN104230932A (zh) 苦参碱衍生物及其制备方法与应用
JPH05500205A (ja) ヘミンの精製法、新規なヘミン誘導体及びその製造方法
WO2021136491A1 (zh) 一种二肽基肽酶iv抑制剂的晶型及其制备方法和用途
JPS5910563A (ja) α−（Ｎ−ピロリル）−フエニル酢酸誘導体およびその製造方法
CN102731430B (zh) 非布司他的晶型和其制备方法以及应用
BG62228B2 (bg) безводна кристална натриева сол на 5-хлор-3-(2-теноил)-2- оксиндол-1-карбоксамид
CS235223B1 (en) Method of tripiperazine dicitrean preparation
JPH0315632B2 (fi)
CN111171016A (zh) 吲哚生物碱及其衍生物的药学应用
JPS597159A (ja) 結晶性９−デオキソ−９−メチレン−１６，１６−ジメチル−ｐｇｅ↓２
JPS58180498A (ja) 新規アデノシン誘導体およびその製法
CN105399727A (zh) 盐酸瑞伐拉赞新结晶形态
JPH0448777B2 (fi)

Legal Events

Date Code Title Description
IF Valid on the event date
KO00 Lapse of patent

Effective date: 20051202